Related Experiment Video
Updated: May 28, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Neonatal Hypoglycemia: A Systematic Review of International and Local Clinical Guidelines with Clinical Implications
Camelia Rusu1,2, Melinda Matyas3, Boris W Kramer4
1Department of Medical Disciplines, University of Oradea, 410073 Oradea, Romania.
Insights
Neonatal hypoglycemia management guidelines vary internationally. This review compares key guidelines, finding consensus on core principles but highlighting differences in screening and treatment thresholds for newborn blood glucose levels.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Clinical Guidelines
Background:
- Neonatal hypoglycemia is a frequent metabolic issue in newborns.
- Existing international and local guidelines present inconsistencies in screening, thresholds, and management.
Purpose of the Study:
- To systematically review and compare international and local clinical guidelines for neonatal hypoglycemia management.
- To identify variations and commonalities in risk assessment, screening, and treatment protocols.
Main Methods:
- Systematic comparative review of major international and regional guidelines.
- Analysis of recommendations on risk factors, screening protocols, blood glucose thresholds, and NICU admission criteria.
Main Results:
- All reviewed guidelines advocate for targeted screening of at-risk neonates and prompt treatment of symptomatic hypoglycemia.
- Significant variation exists in the recommended timing for initial blood glucose measurement, screening frequency, and minimum glucose thresholds for intervention.
- Current guidelines support oral dextrose gel (40%) as a primary treatment for specific cases.
Conclusions:
- Despite numerical discrepancies, major guidelines align on fundamental principles for managing neonatal hypoglycemia.
- Further research is needed to standardize intervention thresholds and optimize blood glucose measurement strategies.
Abstract:
Background/Objectives: Neonatal hypoglycemia is one of the most common metabolic disturbances in the first 24-72 h of life. Despite its frequency, international and local guidelines differ regarding screening strategies, operational thresholds, and escalation pathways. This study is a systematic comparative review of international and local clinical guidelines regarding neonatal hypoglycemia management. Methods: We performed a systematic review of major guideline frameworks (AAP, BAPM, PES, CPS, Te Tohu Waihonga New Zealand, and Australian state-based guidance) and compared recommendations for risk factors, screening, treatment thresholds, and NICU admission. Results: All guidelines recommended targeted screening of at-risk neonates and immediate treatment of symptomatic hypoglycemia. However, there was no universal agreement on timing of the first blood glucose (BG) measurement, screening frequency, or minimum blood glucose threshold for initiating therapy during the transitional period. Contemporary guidelines endorse 40% oral dextrose gel as first-line therapy in selected cases. Conclusions: Despite numerical differences, guidelines converge on core management principles. Further comparative studies are required to define standardized intervention thresholds and optimal measurement strategies.
Related Concept Videos
Hypoglycemia and Glucagon
Hypoglycemia
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

